Form 4: Imunon Inc. Executive Chairman Acquires Shares

Michael H. Tardugno, Executive Chairman of Imunon, Inc., acquired 42,519 shares of common stock on June 25, 2026, in lieu of a cash bonus.

Summary

• Michael H. Tardugno, Executive Chairman of Imunon, Inc., acquired 42,519 shares of common stock on June 25, 2026.
• The acquisition was made in lieu of 50% of his 2025 annual cash bonus.
• The shares were acquired at a price of $1.72 per share.
• Following this transaction, Mr. Tardugno beneficially owns 59,986 shares of common stock.
• An additional 4,622 shares are held indirectly in an IRA.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While an insider acquisition is generally positive, it's in lieu of cash compensation and lacks broader company performance context.

Positives

• Executive Chairman Michael H. Tardugno has increased his beneficial ownership of Imunon, Inc. stock.
• The acquisition of shares in lieu of cash demonstrates a commitment to retaining capital within the company for operational purposes.
• The transaction price of $1.72 per share may indicate a favorable entry point for the shares.

Negatives

• The filing does not provide details on the company's financial performance or operational status, making it difficult to assess the broader implications of this transaction.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, especially by executive leadership, can be interpreted as a signal of confidence in the company's future prospects, though the specific context of this transaction being in lieu of cash compensation should also be considered.

Stakeholder Impact

• Shareholders may view the Executive Chairman's increased stock ownership positively, potentially signaling confidence in the company's future.
• Employees may see this as a sign of management's commitment to the company's long-term success, especially if the company is prioritizing capital retention over immediate cash payouts.

Key Dates

Keywords

Imunon Inc., Michael H. Tardugno, Form 4, SEC Filing, Insider Transaction, Common Stock, Executive Compensation, Beneficial Ownership